Insights | Eckert & Ziegler Medical

DEC 18

Radiation Therapy

Subdivision of Intermediate Risk Prostate Cancer – Interview with Prof. Dr. Andreas Böhle

A subclassification of intermediate-risk prostate cancer patients could lead to more precise guidelines and subsequently better clinical outcomes.

We talked to Prof. Dr. Andreas Böhle about his recent paper on the matter.

Marius Wölfges

Subdivision of Intermediate Risk Prostate Cancer – Interview with Prof. Dr. Andreas Böhle

NOV 21

Nuclear Medicine

Eckert & Ziegler and DC Pharma Joint-Venture Signing Ceremony 2023

NOV 1

Nuclear Medicine

Illuminating Innovation – Q2/2023

Are you looking for something specific? Browse our categories to find the content you are looking for.

Nuclear Medicine Radiation Therapy Industry Miscellaneous

AUG 28

Radiation Therapy

LDR Brachytherapy in Localized Prostate Cancer – An Interview with Dr. Stefan Carl

JUN 20

Nuclear Medicine

Illuminating Innovation – Q1/2023

Highlights

SEP 16

Nuclear Medicine

From the very beginning – An interview with two founders of Modular-Lab

NOV 18

Nuclear Medicine

Always the right synthesizer for your needs

NOV 18

Nuclear Medicine

A look behind the scenes – Eckert & Ziegler Eurotope cassette production

The Medical Bulletin Subscribe and stay updated

Are you interested in receiving the latest news on our products and recent developments? Do you want to stay updated regarding upcoming events? Our newsletter will be sent regularly and you can unsubscribe anytime.

Email Lists (please select at least one)

Medical

Nuclear Medicine

Radiation Therapy

By clicking subscribe, you give your consent to join our mailing list, to receive the Medical BulletIn and for processing your personal data in accordance with our Data Privacy Statement.